CAS No 36923-21-4 |
7-Amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl esternull |
Inquiry |
CAS No 361442-04-8 |
Saxagliptinnull |
Inquiry |
CAS No 3562-84-3 |
benzbromaronenull |
Inquiry |
CAS No 3613-73-8 |
Dimebolinnull |
Inquiry |
CAS No 356068-93-4 |
5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acidnull |
Inquiry |
CAS No 3543-73-5 |
1-Methyl-5-amino-1H-benzimidazole-2-butanoic Acid Ethyl Esternull |
Inquiry |
CAS No 35467-65-3 |
Hydrazine,(4-methylphenyl)-, hydrochloride (1:?)null |
Inquiry |
CAS No 349-76-8 |
3'-(Trifluoromethyl)acetophenonenull |
Inquiry |
CAS No 32844-27-2 |
4,4'-(1-methylethylidene)bis[2,6-dibromophenol]-poly[oxycarbonyloxy-1,4-phenylene(1-methylethylidene)-1,4-phenylene] copolymernull |
Inquiry |
CAS No 324763-51-1 |
3-Amino-2,2-dimethylpropionamidenull |
Inquiry |
CAS No 324519-68-8 |
(2S,4E)-5-Chloro-N,N-dimethyl-2-(1-methylethyl)-4-pentenamidenull |
Inquiry |
CAS No 324763-39-5 |
4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzenenull |
Inquiry |
CAS No 324519-66-6 |
4-Pentenoic acid,5-chloro-2-(1-methylethyl)-, (2S,4E)-null |
Inquiry |
CAS No 3056-33-5 |
N(2),9-Diacetylguaninenull |
Inquiry |
CAS No 31431-39-7 |
mebendazolenull |
Inquiry |
CAS No 285983-48-4 |
Urea,N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-null |
Inquiry |
CAS No 284461-73-0 |
Sorafenibnull |
Inquiry |
CAS No 284462-37-9 |
4-(4-Aminophenoxy)-N-methylpicolinamidenull |
Inquiry |
CAS No 28090-12-2 |
4-(3-methyl-2-butenyloxy)benzaldehydenull |
Inquiry |
CAS No 25812-30-0 |
gemfibrozilnull |
Inquiry |
CAS No 274901-16-5 |
Vildagliptinnull |
Inquiry |
CAS No 257933-82-7 |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-,(2E)-null |
Inquiry |
CAS No 25442-42-6 |
5'-Trityl-2'-deoxy-2,3'-didehydrothymidinenull |
Inquiry |
CAS No 25658-80-4 |
5-Chloroindolinenull |
Inquiry |
CAS No 25389-94-0 |
KANAMYCIN SULFATE null |
Inquiry |